SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp broad-market selloff is being linked by traders to fears that Democratic control could constrain AI and data-center expansion, weighing on tech-heavy indexes. Others see an overdue valuation reset or forced selling, and debate whether the drop is a buying opportunity or a sign of further losses.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention amid a sharp tech-led selloff, which traders largely link to fears that the midterm results could bring tighter AI and data-center rules; no policy change is confirmed. The community is split between calling the move an overreaction and buying the dip, and warning that it reflects a deeper unwind in AI valuations and could extend further.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is caught in a broad chip and AI-stock selloff as traders fear tighter AI regulation and delayed data-center projects could slow infrastructure spending; concerns about the sustainability of AI investment are adding pressure. The community is split between investors treating the drop as a buying opportunity and bears arguing that the AI trade is a bubble.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns sharp selloff is being tied by traders to fears that Democratic gains and calls for tighter AI regulation could slow data-center expansion and chip demand, alongside a broader retreat from AI and semiconductor stocks. The community is divided between viewing the decline as an overreaction and buying opportunity supported by Microns fundamentals, and warning that the AI trade may be unwinding further.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Fears that Democratic control of Congress could bring tighter AI regulation and slow data-center construction are driving a broad selloff in SNDK and other memory and semiconductor stocks. Traders are split between viewing the decline as an overreaction to policy uncertainty and strong business fundamentals, and warning that AI spending or memory demand could weaken and the downturn deepen.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff has driven attention to SOXL, with traders linking the rout to fears of an AI-trade unwind and potential restrictions on AI and data-center development after Democrats election gains. The community is split between calling the decline an oversold panic and buying the dip, versus warning that losses could deepen in the 3x daily-leveraged ETF.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A broad tech-market selloff has driven SPCX lower, with traders also attributing pressure to election-related concerns about scrutiny of Musk, government ties and AI infrastructure plans. Bulls call the drop an overreaction and buying opportunity, while bears point to political exposure, valuation and potential insider share unlocks as risks.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is caught in a broad semiconductor and AI-stock selloff, with traders focused on fears that the new Democratic congressional majority could bring tougher AI and data-center regulation and slow infrastructure spending. The community is split between treating the drop as panic and a buying opportunity, and warning that AI-capex doubts, high valuations, and concentrated customer demand could mean a deeper correction.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Fears that election-related policy and permitting headwinds could slow AI data-center expansion have driven a sharp selloff in Nebius and other neocloud stocks. Traders are divided between calling the decline an overreaction and warning that buildout delays and financing risks could keep pressure on the sector.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a selloff across AI and data-center stocks, as traders worry that Democratic gains could bring tighter permitting and cite a report linking IREN project delays to some of Microsofts lower AI spending; uncertainty ahead of earnings is adding pressure. Bears point to execution and regulatory risks, while some bulls argue the decline is a sector-wide overreaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CVS Stock Rises After Hours On Alleged Pharmacy Spin-Off Ahead Of Q3 Earnings Report

The decline appears tied to uncertainty around CVSs planned separation of its roughly 9,000 retail pharmacies from Aetna and Caremark, despite a Q3 earnings beat and higher full-year guidance. Traders focused on the unclear structure and implications of the split, which is planned for 2028.

CVS Health CEO on whether Democrats' midterm win will hurt the company

CVS Health CEO on whether Democrats' midterm win will hurt the company...

CVS Health plans to split itself up. Here's why a breakup could make sense now

Analysts say that after a roughly two-year turnaround the company's retail pharmacy business and other units may be strong enough to stand on their own...

Divided Government Sends the Dow Up 1000 Points

Between big Democratic wins and the Trump White House, the U.S. now has the epitome of divided government. 

CVS Q3 Earnings & Revenues Top Estimates, Stock Up in Pre-Market

CVS Health's Q3 earnings and revenues beat estimates as stronger margins and improved operating performance prompt management to raise its 2026 outlook.

CVS Health Q3 2026 Earnings Call Transcript

CVS Health (NYSE:CVS) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Nooks Secures $500M, Launches AI Sales Assistant 'Node': NYSE Content Update

Nooks Secures $500M, Launches AI Sales Assistant 'Node': NYSE Content Update Nooks Secures $500M, Launches AI Sales Assistant 'Node': NYSE Content UpdatePR NewswireNEW YORK, Nov. 4, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Nov. 4, 2026 /PRNewswire/ -- The...

CVS Health (CVS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of +29.01% and +3.20%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

CVS to split off drugstore business in major breakup of healthcare giant

The move would reverse the company's $78 billion acquisition of Aetna, and dismantle the vertically integrated healthcare conglomerate it created in 2018...

CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare

CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare CVS Health Announces Intent to Create Two Distinct Leaders in HealthcarePR NewswireWOONSOCKET, R.I., Nov. 4, 2026 A leading healthcare solutions company with health benefits, pharmacy services and care deliveryThe leading...

$CVS Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $2.09 up 30.62% YoY
• Reported revenue of $108.4B up 5.37% YoY
• CVS Health raised full-year 2026 guidance to at least $6.98 GAAP diluted EPS, $8.20 Adjusted EPS and $15.5B cash flow from operations; projected revenue is at least $420B.

Stocktwits

CVS Health Corp

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.09 up 30.62% YoY
• Reported revenue of $108.4B up 5.37% YoY
• CVS Health raised full-year 2026 guidance to at least $6.98 GAAP diluted EPS, $8.20 Adjusted EPS and $15.5B cash flow from operations; projected revenue is at least $420B.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of $2.09 up 30.62% YoY
• Reported revenue of $108.4B up 5.37% YoY
• CVS Health raised full-year 2026 guidance to at least $6.98 GAAP diluted EPS, $8.20 Adjusted EPS and $15.5B cash flow from operations; projected revenue is at least $420B.

CVS Healths commercial premiums decreased 16.9%; Pharmacy & Consumer Wellness revenue fell amid regulatory price reductions, generic introductions and reimbursement pressure, while management cited continued elevated cost trends and potential macro headwinds.

CVS Health reported improved underlying Government-business performance and a lower Health Care Benefits medical benefit ratio, offers integrated GLP-1 care, and has more than 69% of Aetna Medicare Advantage members in 4-star-or-higher plans.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>The structure and timing remain fluid and could change, the report said, adding that an announcement could come as early as this week’s third-quarter results.</li><li>CVS is slated to report third-quarter earnings before the market opens on Wednesday.</li><li>The potential split arrives amid growing scrutiny of companies that own both pharmacy benefit managers and pharmacies.</li></ul><p>Shares of CVS Health (CVS) climbed 2% in after-hours trading on Tuesday following reports that the company is exploring a separation of its retail pharmacy business from its insurance and pharmacy benefit management operations.</p><p>The stock closed the regular session up roughly 3.3% and extended gains after hours.</p><h2 class="st-heading-2">Break-Up Would Unwind CVS's Aetna Integration</h2><p>The Financial Times, citing people familiar with the matter, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/2478a5ea-263a-4f4f-ac96-7d619fb39bb8?syn-25a6b1a6=1">said</a> CVS is considering spinning off its retail pharmacy division as a separately listed company. The division has approximately 9,000 stores expected to generate about one-third of the company’s projected $417 billion in revenue this year.</p><p>Such a move would reverse the vertical integration created by CVS’s $78 billion acquisition of Aetna in 2018, the report noted. Under the plans being discussed, the remaining company would keep the Aetna insurer and Caremark pharmacy benefit manager together, along with other acquired care businesses such as Signify Health and Oak Street Health.</p><p>The structure and timing remain fluid and could change, the report said, adding that an announcement could come as early as this week’s third-quarter results. CVS is slated to report third-quarter earnings before the market opens on Wednesday. According to data from Fiscal AI, Wall Street on average expects the company to report revenue of $104.69 billion and earnings per share of $1.65.</p><h2 class="st-heading-2">Political Pressure On Combined Ownership</h2><p>The potential split arrives amid growing scrutiny of companies that own both pharmacy benefit managers and pharmacies, FT noted. States including Tennessee and Arkansas have advanced measures restricting such combinations. Bipartisan federal legislation has also been reintroduced in the Senate to prohibit co-ownership of pharmacy benefit managers and pharmacies.</p><h2 class="st-heading-2">CVS Turnaround Under New Leadership</h2><p>CVS Health has staged a notable recovery under chief executive David Joyner, who took the helm in October 2024 after activist investor Glenview Capital pushed for changes that resulted in the departure of former CEO Karen Lynch.</p><p>Shares, which sank to a 10-year low in December 2024, have recovered since, owing largely to a turnaround at the Aetna insurance unit. The company’s retail pharmacy business is the weaker part of the company’s portfolio, growing more slowly compared to its other businesses. The company currently has a market valuation of $117 billion.</p><h2 class="st-heading-2">How Did CVS Retail Traders React?</h2><p>On Stocktwits, retail sentiment around <a class="mention" data-mention="$CVS" data-symbol-id="CVS" href="https://stocktwits.com/symbol/CVS" target="_blank">CVS stock</a> stayed in 'neutral' territory over the past 24 hours, while message volume stayed at 'normal' levels.</p><p>CVS stock has gained 15% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/nrix-slumps-35-after-hours-what-s-driving-the-selloff/cNGXjnzR9d1">NRIX Slumps 35% After-Hours — What’s Driving The Selloff?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

A sign is posted on the exterior of a CVS Pharmacy on Dec. 4, 2017 in San Anselmo, California. (Photo by Justin Sullivan/Getty Images)

CVS is considering spinning off its retail pharmacy division as a separately listed company, The Financial Times reported, citing people familiar with the matter. 

Current Price	$81.57
Prev Close	$79.96
Open	$81.97
Dividend Yield	3.35%
50-Day Moving Average	$90.82
Beta	0.28
Avg. Volume	8.38M
PE Ratio	21.11

52-Week High	$110.68
52-Week Low	$69.51
Market Capitalization	$102.27B
EPS (Annual)	$1.39
Price to Book	1.28
Revenue Per Employee	$1.34M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CVS Fundamentals